Suppression of growth-promoting activity in extract from human uterine cancer by cyclic AMP-mediated mechanism.
Uterine cervical and corpus cancers have been reported to synthesize and secrete the putative peptide mitogen, which elicits a potent proliferative response in the fibroblasts [Res. Commun. Chem. Pathol. Pharmacol. 66, 477-480 (1989)]. The extract from human cervical cancers stimulated [H]thymidine incorporation into human endometrial fibroblasts in a dose-dependent manner. Concomitant exposure of the fibroblasts to dibutyryl cyclic AMP (cAMP) of forskolin, the mitogenic activity of the extract was suppressed by 60%. A higher concentration of the extract did not overcome the inhibitory effects of them, implying that they acted at a stage after the mitogen in extract and specific receptor interaction. These results demonstrated that the growth-promoting activity in cervical cancer extract could be under negative control through cAMP-dependent mechanism.